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The optimal cell lineage for cardiac-regeneration approaches remains mysterious. Additionally, electrical
stimulation promotes cardiomyogenic differentiation of stimulated cells. Therefore, we hypothesized that
electrical conditioning of cardiomyocyte progenitor cells (CMPCs) might enrich their cardiovascular potential.
CMPCs were isolated from human adult atrial appendages, characterized, and electrically stimulated for 7 and
14 days. Electrical stimulation modulated CMPCs gene and protein expression, increasing all cardiac markers.
GATA-binding protein 4 (GATA4) early transcription factor was significantly overexpressed (P = 0.008), but also
its coactivator myocyte enhancer factor 2A (MEF2A) was upregulated (P = 0.073) under electrical stimulation.
Moreover, important structural proteins and calcium handling-related genes were enhanced. The cardioregeneration
capability of CMPCs is improved by electrical field stimulation. Consequently, short-term electrical stimulation
should be a valid biophysical approach to modify cardiac progenitor cells toward a cardiogenic phenotype, and
can be incorporated into transdifferentiation protocols. Electrostimulated CMPCs may be best-equipped cells for
myocardial integration after implantation.Introduction
Cardiovascular diseases remain the leading cause of death
in Western countries. Alternative strategies beyond current
guidelines are actively sought to repair injured cardiac tis-
sue, and stem cell-based therapies provide a promising path
toward achieving this goal. In the past decade, progenitors
from different origins have been studied for cardiac-
regeneration purposes; however, the optimal cell lineage
remains elusive. Despite the existence of resident cardiac
stem cells, such as human cardiomyocyte progenitor cells
(CMPCs), the regenerative capacity of the heart is limited.
The therapeutic potential of CMPCs was outlined in a
pivotal report by Smits et al. [1], who demonstrated that* Correspondence: abayes.germanstrias@gencat.cat
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article, unless otherwise stated.CMPCs exhibit a certain degree of in situ differentiation
into cardiomyocytes, smooth muscle cells, and endothe-
lial cells after intramyocardial injection in a postinfarcted
model in mice. Cardiomyogenic differentiation has also
been promoted in a cardiac-mimetic electrical stimula-
tion model in vitro [2]. Accordingly, we hypothesized
that the biophysical conditioning of CMPCs by electrical
stimuli might enhance their cardiovascular potential and
render them (once electrostimulated) fitting candidates
for cardiac cell-therapy strategies.
In this study, we reported CMPCs isolation and
characterization; we designed an electrostimulation proto-
col based on 2-millisecond pulses of 25 mV/cm alternat-
ing current, and evidenced gene and protein modulations
after electric-field stimulation.Results
CMPCs were precisely isolated from human adult atrial
appendages after the clonogenic method, as previouslyed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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by the local Ethics Committee (Germans Trias i Pujol
University Hospital Ethics Committee), and informed
consent was obtained from all patients. The study protocol
conformed to the principles outlined in the Declaration of
Helsinki.
Subsequent characterization of CMPCs demonstrated
a spindle-shaped, highly proliferating (duplication time:
1.5 ± 0.3 days) population of cells showing high Sca-1
and CD105, low CD34, and undetectable CD14, CD45,
and CD133 expressions (Figure 1A-C). A representative
CMPC cardiac gene-expression pattern was also found
under basal conditions (Figure 1D). In particular, MEF2A
and GATA4 transcription factors were expressed, as well
as α-actinin, cardiac troponin I (cTnI), the calcium handling-
related protein, sarcoplasmic endoplasmic reticulum Ca2+
ATPase 2 (SERCA2), and the cell-connection protein,
connexin43 (Cx43). Baseline expression of the endothelial
marker CD31 was also confirmed in control CMPCs at both
gene and protein levels (Figure 1D,E). See Additional file 1
for detailed explanation of materials and methods.
Next, CMPCs were electrostimulated by using a custom-
made stimulation-unit setup, which comprised a monophasic
programmable electrical device, an electrical isolationFigure 1 Baseline characterization of CMPCs. (A) Bright-field image of C
in control CMPCs. (C) CD31 expression (green) in control CMPCs. (D) CMPC
RT-PCR, showing fold expression (2-ΔCT) of cardiomyogenic and angiogenicstage, two printed circuit boards, which enable the fast
and robust connection of the electrodes, and a biocompatible
polydimethylsiloxane silicone-patterned construct, de-
signed to provide structural support to cells and elec-
trodes (Figure 2A). Although pulses produced by the
stimulator are monophasic, the transformer-based isolator
creates a negative low-level exponential pulse after each
square positive pulse, which ensures zero direct-current
average voltage to avoid electrolysis.
The electrical-stimulation protocol consisted of submit-
ting 30,000 seeded cells to 2-ms monophasic square-wave
pulses of 25 mV/cm at 1 Hz (alternating current) for 7
and 14 days [4].
Electrical stimulation modulated CMPC gene and pro-
tein expression (Figure 2B,C). Figure 2B shows the fold
change of the studied cardiac markers at 7 and 14 days.
All cardiac markers increased their expression after 14
days of stimulation.
A statistically significant overexpression of GATA4 was
observed (P = 0.008), but also MEF2A (P = 0.073) was
upregulated under electrical stimulation. MEF2 proteins
are recruited through their DNA-binding domains by
the early transcription factor GATA4 to activate cardiac
promoters. Both transcription factors are expressed inMPCs under standard culture conditions. (B) Sca-1 expression (green)
surface-marker expression profile under basal conditions. (E) Real-time
genes in control CMPCs.
Figure 2 (See legend on next page.)
Llucià-Valldeperas et al. Stem Cell Research & Therapy 2014, 5:93 Page 3 of 5
http://stemcellres.com/content/5/4/93
(See figure on previous page.)
Figure 2 Genetic and protein analysis after electrical stimulation. (A) Experimental setup for electric stimulation: the electric
stimulator is connected to the printed circuit boards through an isolator stage. (B) Real-time RT-PCR of cardiac genes in electrically
stimulated CMPCs, as compared with control, at 7 and 14 days. All RT-PCR values were analyzed in duplicate, normalized to GAPDH
expression, and shown as fold-change mean ± SEM; *P < 0.05 and #P < 0.10, 7-day (n = 5) versus 14-day (n = 10) stimulation. (C) Actin
fibers (red) and Cx43 (green), sarcomeric α-actinin (red) and GATA4 (green), and SERCA2 (red) and MEF2 (green) expressions in control
(a, c, e) and electrostimulated (b, d, f) CMPCs, respectively. Nuclei were counterstained with Hoechst 33342. Scale bars = 50 μm. Arrowheads, positive
staining of nuclear proteins (MEF2 and GATA4).
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patterns after electrical stimulation.
The presence of early transcription factors might con-
ceivably enhance cardiac protein expression to achieve fur-
ther a cardiomyocyte-like phenotype (for example, gap
junctions for electrical coupling, and sarcomeric proteins
for mechanical contraction) (Figure 2Ca-f). Cx43 proteins
form gap junctions, which are key elements for impulse
propagation throughout the heart syncytium. Cx43 protein
was observed in the cytoplasm, as well as at the plasma
membrane, particularly in stimulated cells (Figure 2Ca,b),
in which its expression was improved. Main structural
proteins for the contractile apparatus, such as cTnI and
α–actinin, were also augmented (P = 0.093 and P > 0.1,
respectively), although they do not show a striated pattern
(Figure 2Cc,d). The absence of sarcomeres could suggest
an early stage in the cardiomyogenic differentiation [5].
Additionally, SERCA2 protein was expressed in both
conditions (Figure 2Ce,f ), and was also slightly enhanced
after 14 days of electrical stimulation (P > 0.1). SERCA2
proteins are intracellular pumps, which are located in
the sarcoplasmic or endoplasmic reticula of muscle cells
that are involved in the regulation of the cardiac con-
traction/relaxation cycle.
Conclusions
In sum, these data demonstrate that electric-field stimula-
tion of CMPCs enhances cardiac gene expression. Gene
modulation is translated to the protein level to promote
CMPC phenotype differentiation. Short-term electrical
stimulation appears to be a valid biophysical method to
modify cardiac progenitor cells toward a cardiogenic
phenotype, and can be included in transdifferentiation
protocols. Electrostimulated CMPCs may be best-equipped
for myocardial integration after transplantation.
Additional file
Additional file 1: Detailed description of materials and methods
used in this study in the additional file.
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